17-octadecynoic acid

17-octadecynoic acid is a lipid of Fatty Acyls (FA) class. 17-octadecynoic acid is associated with abnormalities such as Renal tubular disorder, Hypertensive disease, abnormal fragmented structure, Blood Clot and Subarachnoid Hemorrhage. The involved functions are known as Hypoxia, Pathological Dilatation, Anabolism, Biochemical Pathway and Stimulus. 17-octadecynoic acid often locates in Endothelium, Muscle, Protoplasm, Microsomes and Membrane. The associated genes with 17-octadecynoic acid are P4HTM gene, EDNRA gene, Gene Family, IMPACT gene and PPP1R1A gene. The related lipids are 17-octadecynoic acid, Fatty Acids, 1-oleoyl-2-acetoyl-sn-glycerol and fatty acid analog.

Cross Reference

Introduction

To understand associated biological information of 17-octadecynoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 17-octadecynoic acid?

17-octadecynoic acid is suspected in Hypertensive disease, Renal tubular disorder, Blood Clot, Subarachnoid Hemorrhage, Renal vascular disorder and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 17-octadecynoic acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Hyperthyroidism D006980 12 associated lipids
Cicatrix D002921 9 associated lipids
Glioblastoma D005909 27 associated lipids
Corneal Neovascularization D016510 8 associated lipids
Total 5

PubChem Associated disorders and diseases

What pathways are associated with 17-octadecynoic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 17-octadecynoic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 17-octadecynoic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 17-octadecynoic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 17-octadecynoic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 17-octadecynoic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 17-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 156
Authors Title Published Journal PubMed Link
Nakamura T et al. Design and synthesis of 1-(4-benzoylphenyl)imidazole derivatives as new potent 20-HETE synthase inhibitors. 2004 Bioorg. Med. Chem. Lett. pmid:15454216
Ljuca F et al. Contribution of Ras farnesyl transferase, MAP kinase and cytochrome P-450 metabolites to endothelin-1 induced hypertension. 2011 Bosn J Basic Med Sci pmid:21619553
Grainger J and Boachie-Ansah G Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. 2001 Br. J. Pharmacol. pmid:11682448
Chataigneau T et al. Epoxyeicosatrienoic acids, potassium channel blockers and endothelium-dependent hyperpolarization in the guinea-pig carotid artery. 1998 Br. J. Pharmacol. pmid:9504399
Gao YJ et al. Mechanisms of hydrogen-peroxide-induced biphasic response in rat mesenteric artery. 2003 Br. J. Pharmacol. pmid:12684264
McGuire JJ et al. Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles. 2002 Br. J. Pharmacol. pmid:11786491
Edwards G et al. Further investigations into the endothelium-dependent hyperpolarizing effects of bradykinin and substance P in porcine coronary artery. 2001 Br. J. Pharmacol. pmid:11487526
Marchetti J et al. Bradykinin attenuates the [Ca(2+)](i) response to angiotensin II of renal juxtamedullary efferent arterioles via an EDHF. 2001 Br. J. Pharmacol. pmid:11159728
Jiang F et al. Mechanisms of nitric oxide-independent relaxations induced by carbachol and acetylcholine in rat isolated renal arteries. 2000 Br. J. Pharmacol. pmid:10903955
Buus NH et al. Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries. 2000 Br. J. Pharmacol. pmid:10694219
Krummen S et al. ROS-sensitive cytochrome P450 activity maintains endothelial dilatation in ageing but is transitory in dyslipidaemic mice. 2006 Br. J. Pharmacol. pmid:16474414
Bruce JI and Elliott AC Pharmacological evaluation of the role of cytochrome P450 in intracellular calcium signalling in rat pancreatic acinar cells. 2000 Br. J. Pharmacol. pmid:11030726
Zygmunt PM et al. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. 1996 Br. J. Pharmacol. pmid:8818337
Edwards G et al. Effects of cytochrome P450 inhibitors on potassium currents and mechanical activity in rat portal vein. 1996 Br. J. Pharmacol. pmid:8904643
Faraci FM and Sobey CG Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation. 1999 Brain Res. pmid:10064823
Cheng ZJ et al. Vascular dysfunction in type 2 diabetic TallyHo mice: role for an increase in the contribution of PGH2/TxA2 receptor activation and cytochrome p450 products. 2007 Mar-Apr Can. J. Physiol. Pharmacol. pmid:17612649
Grider JS et al. P450 arachidonate metabolites mediate bradykinin-dependent inhibition of NaCl transport in the rat thick ascending limb. 1997 Can. J. Physiol. Pharmacol. pmid:9114929
Randriamboavonjy V et al. The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation. 2005 Cardiovasc. Res. pmid:15639488
Bakker EN et al. Signal transduction in spontaneous myogenic tone in isolated arterioles from rat skeletal muscle. 1999 Cardiovasc. Res. pmid:10325970
Nithipatikom K et al. Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway. 2004 Circ. Res. pmid:15388642